BioSpace News Archive

KAIST GSI forum explores big questions in the medical and bio-engineering revolution caused by the COVID-19 in fight against infectious diseases and life quality

Portfolio includes prescription products in Takeda’s Cardiovascular/Metabolic and Anti-inflammatory therapeutic areas along with Calcium

Aridis Pharmaceuticals, Inc. announced it has reached an agreement with the US Food and Drug Administration to simplify the Company’s AR-501 Phase 2 trial design for the treatment of chronic lung infections associated with cystic fibrosis.

Freudenberg Medical, a global developer and manufacturer of specialty components and finished products for the medical device industry, has acquired the dedicated manufacturing equipment and associated assets utilized by Merit Medical Systems, Inc. in its hypotube manufacturing business.

This year’s hybrid virtual and physical experience includes a refreshed app, customizable virtual runners; Iconic R&B artist Jully Black will kick off opening ceremonies

Results from pivotal phase 2/3 study met co-primary endpoints for improvement in trough plasminogen activity levels and reduction in lesion size

Invivoscribe, Inc., an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies, announced key members of the leadership team hired to direct Invivoscribe Therapeutics, Inc., its fully integrated drug development engine.

Fiscal year 2020 has been a pivotal year for Astrotech Corporation. We had the first sales of our TRACER 1000™ explosives trace detector, we completed a number of successful field trials including a live screening with the U.S. Transportation Security Administration at Miami International Airport, and we signed a key contract with a global shipping and logistics company.

Quotient Limited, headquartered in Eysins, Switzerland, announced that the Company and Ortho Clinical Diagnostics have signed a binding letter of intent that confirms the termination of their former distribution agreement and related contracts and resolves all their disputes over the former distribution agreement.

IDE Approval to Pave the Way for Pivotal Study of CGuard System for Carotid Artery Disease and Stroke Prevention in the United States